Interests are in big data and network approaches that utilize clinical and basic science data (genomics, high throughput screening, etc.) to accelerate development of novel therapeutics.
Dr. Tsinoremas is focused on high throughput chemical approaches integrated with state-of-the art post-genome sequence, cell, molecular, and in vivo biology to provide a rapid and facile mechanism for enhancing the process of biomedical science and the discovery of proof-of-concept molecules